Welcome to Research
We aim to ensure sustainable access to high quality infection prevention and control, diagnostics and antimicrobial therapy both in usual care and in outbreak settings.
See some of the most important goals for this research program.
Roger Brüggemann's research group aims to develop innovative and personalized antimicrobial pharmacological approaches in order to reduce infectious disease related morbidity and mortality.
David Burger's research group uses clinical pharmacology to improve antiviral therapy globally. We focus mainly on HIV. Our main areas of interest are drug-drug interactions, pediatric pharmacology and therapeutic drug monitoring.
Heiman Wertheim's research group works on feasible solutions with impact to tackle infectious diseases in various settings, from low income to high income.
prof. dr. Heiman Wertheim